Aldeyra Therapeutics Statistics

Total Valuation

ALDX has a market cap or net worth of $321.64 million. The enterprise value is $255.28 million.

Market Cap	321.64M
Enterprise Value	255.28M

Important Dates

The next estimated earnings date is Friday, August 22, 2025, before market open.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

ALDX has 59.90 million shares outstanding. The number of shares has increased by 0.86% in one year.

Current Share Class	59.90M
Shares Outstanding	59.90M
Shares Change (YoY)	+0.86%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	3.13%
Owned by Institutions (%)	39.61%
Float	47.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.82
P/TBV Ratio	5.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.28.

Current Ratio	2.86
Quick Ratio	2.77
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.00

Financial Efficiency

Return on equity (ROE) is -65.91% and return on invested capital (ROIC) is -36.06%.

Return on Equity (ROE)	-65.91%
Return on Assets (ROA)	-31.58%
Return on Invested Capital (ROIC)	-36.06%
Return on Capital Employed (ROCE)	-96.18%
Revenue Per Employee	n/a
Profits Per Employee	-$5.62M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.53% in the last 52 weeks. The beta is 0.75, so ALDX's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+14.53%
50-Day Moving Average	4.25
200-Day Moving Average	4.53
Relative Strength Index (RSI)	66.51
Average Volume (20 Days)	1,108,163

Short Selling Information

The latest short interest is 5.03 million, so 8.41% of the outstanding shares have been sold short.

Short Interest	5.03M
Short Previous Month	4.63M
Short % of Shares Out	8.41%
Short % of Float	10.56%
Short Ratio (days to cover)	4.15

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.31M
Pretax Income	n/a
Net Income	-50.62M
EBITDA	-53.06M
EBIT	-53.31M
Earnings Per Share (EPS)	-$0.85

Full Income Statement

Balance Sheet

The company has $81.92 million in cash and $15.56 million in debt, giving a net cash position of $66.36 million or $1.11 per share.

Cash & Cash Equivalents	81.92M
Total Debt	15.56M
Net Cash	66.36M
Net Cash Per Share	$1.11
Equity (Book Value)	55.29M
Book Value Per Share	0.92
Working Capital	55.03M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-41.04M
Capital Expenditures	n/a
Free Cash Flow	-41.04M
FCF Per Share	-$0.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.86%
Shareholder Yield	-0.86%
Earnings Yield	-15.74%
FCF Yield	-12.76%

Analyst Forecast

The average price target for ALDX is $9.50, which is 76.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	76.91%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1